169 related articles for article (PubMed ID: 34860565)
1. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.
Chipidza FE; Kayembe MKA; Nkele I; Efstathiou JA; Chabner BA; Abramson J; Dryden-Peterson SL; Sohani AR
JCO Glob Oncol; 2021 Sep; 7():1620-1632. PubMed ID: 34860565
[TBL] [Abstract][Full Text] [Related]
2. Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies.
Boot MV; Schaapveld M; Van den Broek EC; Hijmering NJ; Group P; Van der Oord K; Van Leeuwen FE; Dinmohamed AG; Koens L; De Jong D
Haematologica; 2023 May; 108(5):1349-1358. PubMed ID: 36263842
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
5. Investigation of lymphoid lesions of the head and neck using combined fine needle aspiration cytology and flow cytometry: Accuracy and pitfalls.
Crous H; Gillam A; Kalokerinos MA; Knezevic S; Hobson P; Papadimos DJ; Shield PW
Cytopathology; 2019 Jul; 30(4):370-377. PubMed ID: 30985042
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary mediastinal large B cell lymphoma by flow cytometry.
Cherian S; Fromm JR
Cytometry B Clin Cytom; 2018 May; 94(3):459-467. PubMed ID: 28732145
[TBL] [Abstract][Full Text] [Related]
7. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
[TBL] [Abstract][Full Text] [Related]
8. The role of bone marrow biopsy and FDG-PET/CT in identifying bone marrow infiltration in the initial diagnosis of high grade non-Hodgkin B-cell lymphoma and Hodgkin lymphoma. Accuracy in a multicenter series of 372 patients.
Chen-Liang TH; Martin-Santos T; Jerez A; Senent L; Orero MT; Remigia MJ; Muiña B; Romera M; Fernandez-Muñoz H; Raya JM; Fernandez-Gonzalez M; Lancharro A; Villegas C; Carlos Herrera J; Frutos L; Luis Navarro J; Uña J; Igua C; Sanchez-Vaño R; Cozar Mdel P; Contreras J; Sanchez-Blanco JJ; Perez-Ceballos E; Ortuño FJ
Am J Hematol; 2015 Aug; 90(8):686-90. PubMed ID: 25925613
[TBL] [Abstract][Full Text] [Related]
9. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
10. Clinical and misdiagnosed analysis of primary pulmonary lymphoma: a retrospective study.
Yao D; Zhang L; Wu PL; Gu XL; Chen YF; Wang LX; Huang XY
BMC Cancer; 2018 Mar; 18(1):281. PubMed ID: 29530011
[TBL] [Abstract][Full Text] [Related]
11. CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma.
Hoffmann C; Schommers P; Wolf E; Müller M; Schultze A; Krznaric I; Stoehr A; Wolf T; Fäktenheuer G; Stier B; Wyen C; Hentrich M
AIDS; 2016 Mar; 30(5):753-60. PubMed ID: 26605513
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study.
Pavlovsky M; Cubero D; Agreda-Vásquez GP; Enrico A; Mela-Osorio MJ; San Sebastián JA; Fogliatto L; Ovilla R; Avendano O; Machnicki G; Barreyro P; Trufelli D; Villanova P
JCO Glob Oncol; 2022 Mar; 8():e2100265. PubMed ID: 35486884
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, pathological distribution, and prognostic factors in non-Hodgkin lymphoma of Waldeyer's ring: nationwide Korean study.
Lee SJ; Suh CW; Lee SI; Kim WS; Lee WS; Kim HJ; Choi CW; Kim JS; Shin HJ;
Korean J Intern Med; 2014 May; 29(3):352-60. PubMed ID: 24851070
[TBL] [Abstract][Full Text] [Related]
14. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
[TBL] [Abstract][Full Text] [Related]
15. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification].
Wang JF; Wang YZ; Chen ZW; Taylor RC
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):218-23. PubMed ID: 16776979
[TBL] [Abstract][Full Text] [Related]
17. Livin, a novel marker in lymphoma type distinction.
Tanhaei AP; Ziaei A; Mazrouei S; Keyhanian K; Salehi M
Ann Diagn Pathol; 2014 Jun; 18(3):157-62. PubMed ID: 24767895
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
Grossman DM; Hanson CA; Schnitzer B
Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma.
Intragumtornchai T; Rotnakkarin P; Sutcharitchan P; Wannagrairoj P
Clin Lymphoma; 2003 Jun; 4(1):52-5. PubMed ID: 12837156
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
